Form 4: Tilray CEO's Performance-Based Stock Vesting

Tilray Brands, Inc. CEO Irwin D. Simon's performance-based restricted stock units vested, resulting in the acquisition of 706,216 shares after meeting key EBITDA targets.

Summary

• Irwin D. Simon, President and CEO of Tilray Brands, Inc., acquired 706,216 shares of common stock on July 31, 2025, through the vesting of 353,108 performance-based restricted stock units (2022 PSUs).
• The vesting was contingent on achieving pre-established performance parameters related to aggregate EBITDA from the HEXO transaction, which were successfully satisfied.
• To cover tax withholding obligations, 374,295 shares were disposed of by the company at a price of $0.58 per share.
• Following these transactions, Simon's direct beneficial ownership of Tilray common stock is 4,826,493 shares.
• 墾],
• positives": [ "The underlying performance condition for the 2022 PSUs, tied to aggregate EBITDA from the HEXO transaction, was satisfied, indicating successful operational performance.
• Irwin D. Simon, President and CEO, acquired a significant number of shares (706,216) through the vesting of performance-based equity, aligning his interests with shareholders.

Sentiment

Score: 7

Explanation: The filing indicates successful achievement of performance targets tied to a significant acquisition (HEXO transaction), leading to the vesting of executive equity. This is a positive signal regarding the company's operational performance and management's alignment with shareholder interests, despite the shares withheld for tax.

Negatives

• A substantial number of shares (374,295) were withheld by the company to satisfy tax withholding obligations associated with the PSU vesting, reducing the net shares received by the CEO.

Future Outlook

The filing indicates that pre-established performance parameters related to aggregate EBITDA from the HEXO transaction were satisfied, which is a positive indicator of past performance leading to future compensation. No explicit forward-looking guidance or projections are provided.

Management Comments

• The underlying performance condition was satisfied.

Industry Context

This filing reflects an executive compensation event within the cannabis industry, specifically related to Tilray Brands, Inc. The successful achievement of performance targets tied to the HEXO transaction suggests progress in integration or synergy realization within the highly competitive and evolving cannabis market.

Comparison to Industry Standards

• The vesting of performance-based equity, contingent on specific financial metrics like EBITDA, is a standard practice in executive compensation across various industries, including the cannabis sector.
• The specific EBITDA targets related to the HEXO transaction are internal to Tilray and not directly comparable without knowing the specific targets and the financial performance of comparable mergers or acquisitions in the cannabis industry. However, the satisfaction of these targets suggests successful execution relative to internal benchmarks.

Related Party Transactions

• The transaction involves the company (Tilray Brands, Inc.) withholding shares from its President and CEO (Irwin D. Simon) to satisfy tax obligations related to equity vesting, which is a common type of related party transaction in executive compensation.

Stakeholder Impact

• Shareholders: The vesting of performance-based equity due to met EBITDA targets could be viewed positively, indicating management's successful execution of strategic initiatives (HEXO transaction) and alignment of executive incentives with company performance. The CEO's continued significant ownership stake (4,826,493 shares) reinforces this alignment.

Key Dates

Recommendation

This Form 4 indicates that Tilray Brands, Inc. successfully met performance targets related to the HEXO transaction, leading to the vesting of a significant amount of performance-based equity for its CEO. This is a positive signal regarding the company's operational execution and the value derived from the acquisition. However, as a single insider transaction report, it provides limited insight into the company's overall financial health or future prospects. While the performance achievement is encouraging, it's not sufficient on its own to warrant a strong buy or sell recommendation. Investors should consider this positive operational indicator in conjunction with comprehensive financial statements and broader market analysis.

Keywords

Tilray Brands, TLRY, SEC Form 4, Insider Trading, Stock Vesting, Performance Stock Units, CEO Compensation, EBITDA, HEXO Transaction, Cannabis Industry